Emerging resistance pathways in lung cancer: what has ROS-1 taught us? (2018)
Attributed to:
MSCTRAIL for lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21037/tlcr.2017.11.13
PubMed Identifier: 29531896
Publication URI: http://europepmc.org/abstract/MED/29531896
Type: Journal Article/Review
Volume: 7
Parent Publication: Translational lung cancer research
Issue: Suppl 1
ISSN: 2218-6751